Seiwert, T. Y., Darga, T., Haraf, D., Blair, E. A., Stenson, K., Cohen, E. E. W., . . . Vokes, E. E. (2013). A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. Oxford University Press.
Styl ChicagoSeiwert, T. Y., et al. A Phase I Dose Escalation Study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) With Concurrent Chemoradiotherapy in Patients With Recurrent Head and Neck Cancer Undergoing Reirradiation. Oxford University Press, 2013.
Citace podle MLASeiwert, T. Y., et al. A Phase I Dose Escalation Study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) With Concurrent Chemoradiotherapy in Patients With Recurrent Head and Neck Cancer Undergoing Reirradiation. Oxford University Press, 2013.